{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:02:38Z","timestamp":1784768558637,"version":"3.55.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2508085MH219"],"award-info":[{"award-number":["2508085MH219"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574392"],"award-info":[{"award-number":["82574392"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["YJS20240064"],"award-info":[{"award-number":["YJS20240064"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.taap.2026.117866","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:49:51Z","timestamp":1778600991000},"page":"117866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel GLP-1RA-like effects of Bafetinib: a preliminary study integrated in vitro screening and in vivo validation"],"prefix":"10.1016","volume":"512","author":[{"given":"Xin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quantong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gefei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShenAo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2026.117866_bb0005","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jconrel.2013.05.031","article-title":"Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan","volume":"170","author":"Ahn","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.taap.2026.117866_bb0010","first-page":"837","article-title":"Systematic review examines GLP-1 drugs' effectiveness and safety in patients without diabetes","volume":"333","author":"Anderer","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.taap.2026.117866_bb0015","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2026.117866_bb0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11892-019-1176-8","article-title":"How, when, and where do human \u03b2-cells regenerate?","volume":"19","author":"Basile","year":"2019","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.taap.2026.117866_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109152","article-title":"Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: a cost-utility analysis based on the EXSCEL trial","volume":"183","author":"Becker","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.taap.2026.117866_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/biom12111612","article-title":"Computational investigation of 1, 3, 4 oxadiazole derivatives as lead inhibitors of VEGFR 2 in comparison with EGFR: density functional theory, molecular docking and molecular dynamics simulation studies","volume":"12","author":"Bilal","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.taap.2026.117866_bb0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41581-022-00645-1","article-title":"Youth-onset type 2 diabetes mellitus: an urgent challenge","volume":"19","author":"Bjornstad","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.taap.2026.117866_bb0040","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamaophthalmol.2024.6555","article-title":"Semaglutide and nonarteritic anterior ischemic optic neuropathy","volume":"143","author":"Cai","year":"2025","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.taap.2026.117866_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154175","article-title":"Cyclocarya paliurus triterpenoids suppress hepatic gluconeogenesis via AMPK-mediated cAMP\/PKA\/CREB pathway","volume":"102","author":"Cao","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.taap.2026.117866_bb0050","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/s41401-020-00589-x","article-title":"A GLP-1 analog lowers ER stress and enhances protein folding to ameliorate homocysteine-induced endothelial dysfunction","volume":"42","author":"Cheng","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.taap.2026.117866_bb0055","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/jcbfm.2015.126","article-title":"Exendin-4-loaded PLGA microspheres relieve cerebral ischemia\/reperfusion injury and neurologic deficits through long-lasting bioactivity-mediated phosphorylated Akt\/eNOS signaling in rats","volume":"35","author":"Chien","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.taap.2026.117866_bb0060","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175634","article-title":"The GLP-1 journey: from discovery science to therapeutic impact","volume":"134","author":"Drucker","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2026.117866_bb0065","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1056\/NEJMcibr2409089","article-title":"Discovery of GLP-1-Based Drugs for the Treatment of Obesity","volume":"392","author":"Drucker","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2026.117866_bb0070","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1073\/pnas.84.10.3434","article-title":"Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line","volume":"84","author":"Drucker","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.taap.2026.117866_bb0075","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1172\/JCI97233","article-title":"Discovery, characterization, and clinical development of the glucagon-like peptides","volume":"127","author":"Drucker","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2026.117866_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.671511","article-title":"Sildenafil alleviates Murine Experimental Autoimmune Encephalomyelitis by triggering autophagy in the spinal cord","volume":"12","author":"Duarte-Silva","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.taap.2026.117866_bb0085","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.nutr.26.061505.111223","article-title":"Glucagon-like Peptide-2","volume":"26","author":"Estall","year":"2006","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.taap.2026.117866_bb0090","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cgh.2024.07.021","article-title":"Effects of Glucagon-Like Peptide-1 receptor agonists on upper gastrointestinal endoscopy: a meta-analysis","volume":"23","author":"Facciorusso","year":"2025","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2026.117866_bb0095","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.2337\/dc25-1840","article-title":"Risk of acute pancreatitis and biliary events after initiation of incretin-based medications in patients with type 2 diabetes","volume":"48","author":"Fang","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.taap.2026.117866_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078483","article-title":"SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study","volume":"385","author":"Fu","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.taap.2026.117866_bb0105","doi-asserted-by":"crossref","first-page":"9918","DOI":"10.1021\/acs.jmedchem.2c00582","article-title":"Design, synthesis, and biological activity of new CB2 receptor ligands: from orthosteric and allosteric modulators to dualsteric\/bitopic ligands","volume":"65","author":"Gado","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2026.117866_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155805","article-title":"Protective effect of melatonin against metabolic disorders and neuropsychiatric injuries in type 2 diabetes mellitus mice","volume":"131","author":"Gao","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.taap.2026.117866_bb0115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jconrel.2015.12.002","article-title":"Controlled release of biologics for the treatment of type 2 diabetes","volume":"240","author":"Gilroy","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.taap.2026.117866_bb0120","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1111\/bph.12750","article-title":"The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo","volume":"171","author":"Grace","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2026.117866_bb0125","article-title":"Discovery of small-molecule antagonists of orexin 1\/2 receptors from traditional chinese medicinal plants with a hypnotic effect","volume":"16","author":"He","year":"2023","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"10.1016\/j.taap.2026.117866_bb0130","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/s42255-024-01113-9","article-title":"GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management","volume":"6","author":"Holst","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.taap.2026.117866_bb0135","doi-asserted-by":"crossref","first-page":"10034","DOI":"10.1038\/s41598-021-89475-y","article-title":"Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus","volume":"11","author":"Hui","year":"2021","journal-title":"Sci. Rep."},{"issue":"1478\u20131487","key":"10.1016\/j.taap.2026.117866_bb0140","article-title":"Target deconvolution with matrix-augmented pooling strategy reveals cell-specific drug-protein interactions","volume":"30","author":"Ji","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.taap.2026.117866_bb0145","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nrd895","article-title":"Protein tyrosine phosphatase 1B inhibitors for diabetes","volume":"1","author":"Johnson","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2026.117866_bb0150","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1038\/s41388-021-01822-5","article-title":"Functional inhibition of cancer stemness-related protein DPP4 rescues tyrosine kinase inhibitor resistance in renal cell carcinoma","volume":"40","author":"Kamada","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2026.117866_bb0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrclinonc.2016.120","article-title":"Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?","volume":"14","author":"Klil-Drori","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.taap.2026.117866_bb0160","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1111\/jcmm.17759","article-title":"Lyn-mediated glycolysis enhancement of microglia contributes to neuropathic pain through facilitating IRF5 nuclear translocation in spinal dorsal horn","volume":"27","author":"Kong","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.taap.2026.117866_bb0165","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41467-025-67087-8","article-title":"Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial","volume":"17","author":"Konstantinopoulos","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2026.117866_bb0170","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1124\/mol.111.072884","article-title":"Polymorphism and ligand dependent changes in human glucagon-like peptide-1 receptor (GLP-1R) function: allosteric rescue of loss of function mutation","volume":"80","author":"Koole","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2026.117866_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106550","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: implications for neurodegenerative disease treatment","volume":"186","author":"Kopp","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2026.117866_bb0180","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.taap.2026.117866_bb0185","article-title":"Safety and tolerability of glucagon-like peptide-1 receptor agonists: a state-of-the-art narrative review","author":"Kunutsor","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.taap.2026.117866_bb0190","article-title":"Hippocampal memory enhancing activity of pine needle extract against scopolamine-induced amnesia in a mouse model","volume":"5","author":"Lee","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2026.117866_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ph17040538","article-title":"Development of syringaldehyde as an agonist of the GLP-1 receptor to alleviate diabetic disorders in animal models","volume":"17","author":"Lee","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.taap.2026.117866_bb0200","doi-asserted-by":"crossref","first-page":"846","DOI":"10.2337\/dc24-1533","article-title":"Cardiovascular and kidney outcomes and mortality with long-acting injectable and oral Glucagon-Like Peptide 1 receptor agonists in individuals with Type 2 Diabetes: a systematic review and meta-analysis of randomized trials","volume":"48","author":"Lee","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.taap.2026.117866_bb0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12974-022-02393-2","article-title":"Exosomes derived from bone-marrow mesenchymal stem cells alleviate cognitive decline in AD-like mice by improving BDNF-related neuropathology","volume":"19","author":"Liu","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.taap.2026.117866_bb0210","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.7150\/thno.90946","article-title":"NPC1 is required for postnatal islet \u03b2 cell differentiation by maintaining mitochondria turnover","volume":"14","author":"Liu","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.taap.2026.117866_bb0215","first-page":"22","article-title":"Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect","volume":"9","author":"Luo","year":"2022","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.taap.2026.117866_bb0220","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1038\/s41467-024-47466-3","article-title":"One substrate many enzymes virtual screening uncovers missing genes of carnitine biosynthesis in human and mouse","volume":"15","author":"Malatesta","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2026.117866_bb0225","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7150\/thno.33410","article-title":"PET\/MRI enables simultaneous in vivo quantification of \u03b2-cell mass and function","volume":"10","author":"Michelotti","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.taap.2026.117866_bb0230","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1038\/s41388-018-0274-4","article-title":"A modified gene trap approach for improved high-throughput cancer drug discovery","volume":"37","author":"Morris","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2026.117866_bb0235","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/jamaophthalmol.2025.2332","article-title":"GLP-1RA exposure and nonarteritic anterior ischemic optic neuropathy prevalence by diabetes status","volume":"143","author":"Nagdeve","year":"2025","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.taap.2026.117866_bb0240","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-022-01604-7","article-title":"Tirzepatide, a dual GIP\/GLP-1 receptor co-agonist for the treatment of Type 2 Diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction","volume":"21","author":"Nauck","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.taap.2026.117866_bb0245","doi-asserted-by":"crossref","first-page":"JC55","DOI":"10.7326\/J24-0028","article-title":"In type 2 diabetes, the effectiveness and side effects of GLP-1 RAs vary","volume":"177","author":"O'Brien","year":"2024","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.taap.2026.117866_bb0250","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41467-025-56914-7","article-title":"Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced\/metastatic endometrial cancer: the ENDOLA phase I\/II trial","volume":"16","author":"Piffoux","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2026.117866_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126331","article-title":"Comparative analysis of orthosteric and allosteric GLP-1R agonists' effects on insulin secretion from healthy, diabetic, and recovered INS-1E pancreatic beta cells","volume":"25","author":"Reed","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2026.117866_bb0260","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2337\/dc12-0709","article-title":"The fate of taspoglutide, a weekly GLP-1 receptor agonist, versus twice-daily exenatide for type 2 diabetes: the T-emerge 2 trial","volume":"36","author":"Rosenstock","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.taap.2026.117866_bb0265","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-018-0624-2","article-title":"Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy","volume":"11","author":"Rossari","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.taap.2026.117866_bb0270","first-page":"1450","article-title":"Bafetinib, a dual Bcr-Abl\/Lyn tyrosine kinase inhibitor for the potential treatment of leukemia","volume":"11","author":"Santos","year":"2010","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.taap.2026.117866_bb0275","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.apsb.2022.10.014","article-title":"\u03b1\/Sulfono-\u03b3-AA peptide hybrids agonist of GLP-1R with prolonged action both in vitro and in vivo","volume":"13","author":"Shi","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.taap.2026.117866_bb0280","series-title":"GLP-1RA and the Risk of Non-Arteritic Anterior Ischaemic Optic Neuropathy in Patients With type 2 Diabetes: A Population-Based Study","author":"Tesfaye","year":"2026"},{"key":"10.1016\/j.taap.2026.117866_bb0285","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1007\/s00125-023-05929-0","article-title":"Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy","volume":"66","author":"Tsch\u00f6p","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.taap.2026.117866_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154862","article-title":"CETSA and thermal proteome profiling strategies for target identification and drug discovery of natural products","volume":"116","author":"Tu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.taap.2026.117866_bb0295","series-title":"Nature Reviews Disease Primers","first-page":"14","volume":"12","author":"Type 2 Diabetes Mellitus","year":"2026"},{"key":"10.1016\/j.taap.2026.117866_bb0300","article-title":"Antitubercular, cytotoxicity, and computational target validation of dihydroquinazolinone derivatives","volume":"11","author":"Venugopala","year":"2022","journal-title":"Antibiotics (Basel, Switzerland)"},{"key":"10.1016\/j.taap.2026.117866_bb0305","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1038\/s41467-023-41892-5","article-title":"Development of cyclopeptide inhibitors of cGAS targeting protein-DNA interaction and phase separation","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2026.117866_bb0310","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41467-024-44737-x","article-title":"A one-two punch targeting reactive oxygen species and fibril for rescuing Alzheimer's disease","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2026.117866_bb0315","first-page":"25","article-title":"Aspartoacylase suppresses prostate cancer progression by blocking LYN activation","volume":"10","author":"Weng","year":"2023","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.taap.2026.117866_bb0320","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1124\/mol.112.084525","article-title":"Differential activation and modulation of the glucagon-like peptide-1 receptor by small molecule ligands","volume":"83","author":"Wootten","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2026.117866_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114171","article-title":"Design, synthesis and structural-activity relationship studies of phanginin A derivatives for regulating SIK1-cAMP\/CREB signaling to suppress hepatic gluconeogenesis","volume":"232","author":"Wu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.taap.2026.117866_bb0330","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12974-022-02548-1","article-title":"MicroRNA-22-3p ameliorates Alzheimer's disease by targeting SOX9 through the NF-\u03baB signaling pathway in the hippocampus","volume":"19","author":"Xia","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.taap.2026.117866_bb0335","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.apsb.2021.12.023","article-title":"Gentiopicroside targets PAQR3 to activate the PI3K\/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism","volume":"12","author":"Xiao","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.taap.2026.117866_bb0340","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.taap.2026.117866_bb0345","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/CIRCRESAHA.119.315861","article-title":"Celastrol attenuates angiotensin II\u2013induced cardiac remodeling by targeting STAT3","volume":"126","author":"Ye","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.taap.2026.117866_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156421","article-title":"SRSF1 is essential for pancreatic \u03b2-cell proliferation and the maintenance of glucose homeostasis in mice","volume":"174","author":"You","year":"2026","journal-title":"Metabolism"},{"key":"10.1016\/j.taap.2026.117866_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.114050","article-title":"Oridonin ameliorates doxorubicin induced-cardiotoxicity via the E2F1\/Sirt6\/PGC1\u03b1 pathway in mice","volume":"181","author":"Yu","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.taap.2026.117866_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156998","article-title":"injection ameliorates non-alcoholic fatty liver disease inhibiting the KLF6\/ABCC5 pathway in mice","volume":"145","author":"Yu","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.taap.2026.117866_bb0365","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12967-025-06461-y","article-title":"Impact of monotherapy and combination therapy with glucagon-like peptide-1 receptor agonists on exosomal and non-exosomal MicroRNA signatures in type 2 diabetes mellitus: a systematic review","volume":"23","author":"Yu","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.taap.2026.117866_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116571","article-title":"Bidirectional crosstalk of the cAMP\/ROS-dependent signaling pathways in inflammatory macrophage: an activation of formononetin","volume":"472","author":"Zhang","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2026.117866_bb0375","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.taap.2026.117866_bb0380","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/s41467-025-68165-7","article-title":"Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a multi-centre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"Zhu","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2026.117866_bb0385","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(24)02255-4","article-title":"Evaluating the benefits of the early use of GLP-1 receptor agonists","volume":"405","author":"Zushin","year":"2025","journal-title":"Lancet"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26001626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26001626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:39:43Z","timestamp":1784767183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X26001626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":77,"alternative-id":["S0041008X26001626"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.117866","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel GLP-1RA-like effects of Bafetinib: a preliminary study integrated in vitro screening and in vivo validation","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.117866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117866"}}